Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Oxidative Damage via the miR-191-5p/DAPK1/AKT Axis in Type 2 Diabetes
Open Access
- 1 January 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0224
Abstract
Human umbilical cord mesenchymal stem cell extracellular vesicles (hucMSC-EVs) exhibit remarkable potential for alleviating type 2 diabetes mellitus (T2DM). However, the role of hucMSC-EVs in T2DM, particularly concerning oxidative damage to pancreatic β cells, remains underexplored. This study utilized a high-fat diet and streptozotocin (STZ)-induced T2DM mouse model and an STZ-induced INS-1 cell damage model to investigate the effects and mechanisms of hucMSC-EVs. In the T2DM mouse model, hucMSC-EVs effectively lowered blood glucose levels, improved lipid metabolism disorders, and preserved liver function. Moreover, hucMSC-EVs enhanced insulin sensitivity and mitigated oxidative damage. Histological analysis confirmed that hucMSC-EVs marked alleviated liver, kidney, and pancreatic tissue damage. In vitro studies demonstrate that hucMSC-EVs enhance glucose absorption and glycogen synthesis in an insulin-resistant HepG2 model and stimulated insulin secretion in INS-1 cells under high-glucose conditions. In the STZ-induced INS-1 oxidative damage model, hucMSC-EVs protect against oxidative damage by increasing antioxidant enzyme activities, reducing reactive oxygen species production, and decreasing cell apoptosis. The effects were partially mediated by the activation of the phosphatidylinositol 3-kinase (PI3K)/AKT and signal transducer and activator of transcription (STAT) signaling pathways, as well as the up-regulation of key antioxidant proteins such as Nrf2, SOD1, and Bcl2. Further research revealed that miR-191-5p, which is enriched in hucMSC-EVs, targets DAPK1 to activate the PI3K/AKT pathway, thereby contributing to the protective effects against oxidative damage. These findings highlight the critical role and underlying mechanisms of hucMSC-EVs in ameliorating metabolic dysfunction in T2DM, particularly the protective effects against oxidative damage, thus providing a novel strategy for the treatment of T2DM.Keywords
Funding Information
- the Jilin Province Science and Technology Development Program (YDZJ202201ZYTS087)
- the Science and Technology Project of the Jilin Provincial Education Departmen (JJKH20221047KJ)
- the Open Project of State Key Laboratory of Supramolecular Structure and Materials (sklssm2024029)
This publication has 46 references indexed in Scilit:
- Potential risks of bone marrow cell transplantation into infarcted heartsBlood, 2007
- Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes MellitusCurrent Neurovascular Research, 2007
- Five-Year Follow-Up After Clinical Islet TransplantationDiabetes, 2005
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureDiabetes Care, 2004
- Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβJournal of Clinical Investigation, 2003
- FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysisAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- Redox Regulation of Forkhead Proteins Through a p66shc -Dependent Signaling PathwayScience, 2002
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaThe Journal of Clinical Endocrinology & Metabolism, 2001
- Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidantsProceedings of the National Academy of Sciences, 1999
- The definition and measurement of antioxidants in biological systemsFree Radical Biology and Medicine, 1995